FDA Inspection 1093310 - Novocol Pharmaceutical of Canada, Inc. - June 18, 2019

Record Details

This FDA Inspection record concerns Novocol Pharmaceutical of Canada, Inc., with an inspection on June 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Novocol Pharmaceutical of Canada, Inc.
Inspection Date: June 18, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 5a9546ca-45e2-4264-a4d2-5e3257507745

Violation Codes1

21 CFR 211.113(b)

Full citation text and observation details available on the Dashboard.